文献速递肝病

慢加急性肝衰竭中的细菌与真菌感染:患病率、特征及对预后影响

Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis.
PubMed 文献 · Gut · 2017-08-28

研究纳入407例慢加急性肝衰竭(ACLF)患者和235例急性失代偿(AD)患者,评估细菌与真菌感染的患病率、特征及对预后的影响。ACLF诊断时37%存在细菌感染,随访4周内46%的剩余患者发生细菌感染,均高于AD患者的25%和18%。ACLF合并细菌感染者全身炎症更重、临床病程更差、90天生存率更低;真菌感染在ACLF中占2%,90天死亡率达71%。

要点

  • ACLF诊断时37%存在细菌感染,随访4周内46%的剩余患者发生细菌感染,均高于AD患者。
  • ACLF合并细菌感染者90天生存率49%,低于无感染者的72.5%。
  • 真菌感染在ACLF中占2%,主要发生于ACLF诊断后,90天死亡率达71%。

核心结论

  • 细菌感染在ACLF中极为常见,感染严重并与强烈的全身炎症、不良临床病程和高死亡率相关。
  • ACLF患者在短期随访内容易发生细菌感染,可能从预防策略中获益。

研究设计与样本

  • 研究纳入407例ACLF患者和235例急性失代偿(AD)患者,评估细菌与真菌感染的患病率、特征及对预后的影响。

主要发现

  • 152例(37%)ACLF患者在诊断时存在细菌感染;剩余255例ACLF患者中46%(n=117)在随访4周内发生细菌感染。
  • AD患者诊断时细菌感染比例为25%,随访期间为18%,均低于ACLF患者(p<0.001)。
  • ACLF合并细菌感染(诊断时或随访期间)者诊断时全身炎症程度更高,最终评估为ACLF 2-3级的比例为47% vs 26%(p<0.001),90天生存概率为49% vs 72.5%(p<0.001)。
  • 细菌感染与ACLF-1和ACLF-2患者的死亡率独立相关。
  • 9例ACLF患者(2%)发生真菌感染,AD患者无真菌感染;真菌感染主要发生于ACLF诊断后(78%),90天死亡率为71%。

关键数值与推荐

  • ACLF诊断时细菌感染患病率为37%(152/407)。
  • ACLF患者随访4周内细菌感染发生率为46%(117/255)。
  • AD患者诊断时细菌感染比例为25%,随访期间为18%(p<0.001)。
  • ACLF合并细菌感染者最终评估为ACLF 2-3级的比例为47% vs 26%(p<0.001)。
  • ACLF合并细菌感染者90天生存概率为49% vs 72.5%(p<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Bacterial infection is a frequent trigger of acute-on-chronic liver failure (ACLF), syndrome that could also increase the risk of infection. This investigation evaluated prevalence and characteristics of bacterial and fungal infections causing and complicating ACLF, predictors of follow-up bacterial infections and impact of bacterial infections on survival. PATIENTS: 407 patients with ACLF and 235 patients with acute decompensation (AD). RESULTS: 152 patients (37%) presented bacterial infections at ACLF diagnosis; 46%(n=117) of the remaining 255 patients with ACLF developed bacterial infections during follow-up (4 weeks). The corresponding figures in patients with AD were 25% and 18% (p<0.001). Severe infections (spontaneous bacterial peritonitis, pneumonia, severe sepsis/shock, nosocomial infections and infections caused by multiresistant organisms) were more prevalent in patients with ACLF. Patients with ACLF and bacterial infections (either at diagnosis or during follow-up) showed higher grade of systemic inflammation at diagnosis of the syndrome, worse clinical course (ACLF 2-3 at final assessment: 47% vs 26%; p<0.001) and lower 90-day probability of survival (49% vs 72.5%;p<0.001) than patients with ACLF without infection. Bacterial infections were independently associated with mortality in patients with ACLF-1 and ACLF-2. Fungal infections developed in 9 patients with ACLF (2%) and in none with AD, occurred mainly after ACLF diagnosis (78%) and had high 90-day mortality (71%). CONCLUSION: Bacterial infections are extremely frequent in ACLF. They are severe and associated with intense systemic inflammation, poor clinical course and high mortality. Patients with ACLF are highly predisposed to develop bacterial infections within a short follow-up period and could benefit from prophylactic strategies.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Fernández J, Acevedo J, Wiest R, et al. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut. 2017. PMID: 28847867. doi:10.1136/gutjnl-2017-314240

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。